BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7724666)

  • 1. Acetylcholine receptor gene expression at the developing neuromuscular junction.
    Duclert A; Changeux JP
    Physiol Rev; 1995 Apr; 75(2):339-68. PubMed ID: 7724666
    [No Abstract]   [Full Text] [Related]  

  • 2. Compartmentalized expression of the alpha- and gamma-subunits of the acetylcholine receptor in recently fused myofibers.
    Piette J; Huchet M; Houzelstein D; Changeux JP
    Dev Biol; 1993 May; 157(1):205-13. PubMed ID: 8482411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of agrin isoforms in Xenopus embryos alters the distribution of synaptic acetylcholine receptors during development of the neuromuscular junction.
    Godfrey EW; Roe J; Heathcote RD
    Dev Biol; 1999 Jan; 205(1):22-32. PubMed ID: 9882495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible loss of acetylcholine receptor clusters at the developing rat neuromuscular junction.
    Bloch RJ; Steinbach JH
    Dev Biol; 1981 Jan; 81(2):386-91. PubMed ID: 6781955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Formation of neuromuscular junction, with special reference to acetylcholine receptor accumulation].
    Kidokoro Y
    Tanpakushitsu Kakusan Koso; 1983 Apr; 28(5):521-30. PubMed ID: 6361886
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of Eph receptors in skeletal muscle and their localization at the neuromuscular junction.
    Lai KO; Ip FC; Cheung J; Fu AK; Ip NY
    Mol Cell Neurosci; 2001 Jun; 17(6):1034-47. PubMed ID: 11414792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unconventional role of neurotransmission in synapse formation.
    Xiong WC; Mei L
    Neuron; 2005 May; 46(4):521-3. PubMed ID: 15944118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish mutants of the neuromuscular junction: swimming in the gene pool.
    Daikoku E; Saito M; Ono F
    J Physiol Sci; 2015 May; 65(3):217-21. PubMed ID: 25782439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synapse formation revisited.
    Davis GW; Eaton B; Paradis S
    Nat Neurosci; 2001 Jun; 4(6):558-60. PubMed ID: 11369932
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrograde signaling in the formation and maintenance of the neuromuscular junction.
    Connor EA; Smith MA
    J Neurobiol; 1994 Jun; 25(6):722-39. PubMed ID: 8071669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synapses form in skeletal muscles lacking neuregulin receptors.
    Escher P; Lacazette E; Courtet M; Blindenbacher A; Landmann L; Bezakova G; Lloyd KC; Mueller U; Brenner HR
    Science; 2005 Jun; 308(5730):1920-3. PubMed ID: 15976301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic system in behavior: the search for mechanisms of action.
    Russell RW
    Annu Rev Pharmacol Toxicol; 1982; 22():435-63. PubMed ID: 6123296
    [No Abstract]   [Full Text] [Related]  

  • 13. Cdk5 at the junction.
    Lee MS; Tsai LH
    Nat Neurosci; 2001 Apr; 4(4):340-2. PubMed ID: 11276216
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of the neuromuscular junction: inductive interactions between cells.
    Dennis MJ
    Annu Rev Neurosci; 1981; 4():43-68. PubMed ID: 7013639
    [No Abstract]   [Full Text] [Related]  

  • 15. Requirements for the formation and maintenance of neuromuscular connections.
    Lømo T
    Curr Top Dev Biol; 1980; 16():253-81. PubMed ID: 7009068
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcholine receptor distribution and synapse elimination at the developing neuromuscular junction of mdx mice.
    Minatel E; Neto HS; Marques MJ
    Muscle Nerve; 2003 Nov; 28(5):561-9. PubMed ID: 14571457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-receptor interaction at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R; Bradley RJ; Müller KD
    Prog Brain Res; 1979; 49():213-23. PubMed ID: 42113
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential muscle-driven synaptic remodeling in the neuromuscular junction after denervation.
    Yampolsky P; Pacifici PG; Witzemann V
    Eur J Neurosci; 2010 Feb; 31(4):646-58. PubMed ID: 20148944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
    Engel AG; Ohno K; Sine SM
    Nat Rev Neurosci; 2003 May; 4(5):339-52. PubMed ID: 12728262
    [No Abstract]   [Full Text] [Related]  

  • 20. [Skeletal muscle receptors].
    Ohta M; Ohta K; Hayashi K
    Nihon Rinsho; 1990 Jul; 48(7):1385-92. PubMed ID: 2169539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.